The ability of TLR4 to activate a pathway leading to central sensitization and behavioral hypersensitivity could provide an opportunity for regulating glial activation, and thus, alleviating chronic pain, such as bone cancer pain. This evidence concerns the gene TLR4 and bone neoplasm.